FDA to Rehire Some Staff
Thursday, May 15, 2025
Print Mail Download info_icon_img/>i
  • FDA is “set to rehire some of the staff that was let go during mass firings in the past three months.” Earlier this year around 3,500 FDA employees, or around 20 percent of its workforce, was let go without cause, and many more left due to retirement, voluntary buyout, and resignation.
  • While FDA and the Department of Health and Human Services have not detailed exactly which positions or programs were cut during the mass layoffs, many included food and medical device reviewers, communications staff, and scientists, as well as travel bookers who coordinate trips for inspectors.
  • Many of the travel bookers have been reported to be on the reinstatement list, according to two anonymous FDA staffers. In addition, food scientists have been told they will be reinstated, and some of the communications staff, including some who worked in the FOIA office, will be rehired.
  • Keller and Heckman will continue to report on staffing and other organizational developments at FDA.
© 2025 Keller and Heckman LLP

Current Public Notices

Current Legal Analysis

More from Keller and Heckman LLP

Regulation on Preventing the Loss of Plastic Pellets to Reduce Microplastic Pollution – Draft Agreement Reached Between the Council and the Parliament
by: Ales Bartl , Alejandra Martínez Perea
Texas Launches Another Investigation into Healthy Claims in Cereals
by: Food and Drug Law at Keller and Heckman
FDA Approves Three New Natural Food Colors
by: Food and Drug Law at Keller and Heckman
FDA and HHS Announce Next Steps in “Operation Stork Speed”
by: Food and Drug Law at Keller and Heckman
FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities
by: Food and Drug Law at Keller and Heckman
FDA and NIH Launch Joint Nutrition Regulatory Science Program
by: Food and Drug Law at Keller and Heckman
FDA Extends Comment Period for Front-of-Package Nutrition Labeling Rule
by: Food and Drug Law at Keller and Heckman
FDA Releases 2023 CORE Annual Report
by: Food and Drug Law at Keller and Heckman
April 2025 Bounty Hunter Plaintiff Claims
by: Sophia B. Castillo , Mitzi Ng Clark
CPSC Advances Lithium-Ion Battery Safety Standard for E-Mobility Devices
by: Sheila A. Millar , Antonia Stamenova-Dancheva
FDA Scores Win in Wages, but Industry Eyes Fifth Circuit Remand in Flavored Vape PMTA Denial Challenge
by: Azim Chowdhury , Eric P. Gotting
Re-evaluation of Acesulfame K (E 950) as Food Additive
by: Food and Drug Law at Keller and Heckman
Draft FDA Budget Proposes Cutting Funding, Shifting Food Inspections to States
by: Food and Drug Law at Keller and Heckman

Upcoming Events

 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters